Target Price | DKK780.37 |
Price | DKK434.05 |
Potential |
79.79%
register free of charge
|
Number of Estimates | 27 |
27 Analysts have issued a price target Novo Nordisk 2026 .
The average Novo Nordisk target price is DKK780.37.
This is
79.79%
register free of charge
DKK1,150.00
164.95%
register free of charge
DKK415.00
4.39%
register free of charge
|
|
A rating was issued by 35 analysts: 23 Analysts recommend Novo Nordisk to buy, 10 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Novo Nordisk stock has an average upside potential 2026 of
79.79%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion DKK | 290.40 | 350.03 |
25.03% | 20.53% | |
EBITDA Margin | 50.95% | 50.09% |
6.23% | 1.68% | |
Net Margin | 34.67% | 34.25% |
2.89% | 1.21% |
27 Analysts have issued a sales forecast Novo Nordisk 2025 . The average Novo Nordisk sales estimate is
This results in the following potential growth metrics:
21 Analysts have issued an Novo Nordisk EBITDA forecast 2025. The average Novo Nordisk EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
19 Novo Nordisk Analysts have issued a net profit forecast 2025. The average Novo Nordisk net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share DKK | 22.67 | 26.99 |
21.42% | 19.06% | |
P/E | 16.08 | |
EV/Sales | 5.72 |
19 Analysts have issued a Novo Nordisk forecast for earnings per share. The average Novo Nordisk EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
BNP PARIBAS EXANE |
Locked
➜
Locked
|
Locked | Jan 05 2025 |
DZ BANK |
Locked
➜
Locked
|
Locked | Jan 02 2025 |
STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
DNB MARKETS |
Locked
➜
Locked
|
Locked | Dec 22 2024 |
TD COWEN |
Locked
➜
Locked
|
Locked | Dec 19 2024 |
GUGGENHEIM SECURITIES LLC |
Locked
➜
Locked
|
Locked | Dec 16 2024 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Jan 06 2025 |
Locked
BNP PARIBAS EXANE:
Locked
➜
Locked
|
Jan 05 2025 |
Locked
DZ BANK:
Locked
➜
Locked
|
Jan 02 2025 |
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Dec 23 2024 |
Locked
DNB MARKETS:
Locked
➜
Locked
|
Dec 22 2024 |
Locked
TD COWEN:
Locked
➜
Locked
|
Dec 19 2024 |
Locked
GUGGENHEIM SECURITIES LLC:
Locked
➜
Locked
|
Dec 16 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.